| abstract |
The present invention relates to transdermal absorption preparations containing tulobuterol useful for treating dyspnea in asthmatic patients. More specifically, the present invention comprises a matrix layer comprising tulobuterol, an acrylic adhesive, a permeation accelerator, and a diffusion enhancer, which is a drug for treating bronchial asthma, the matrix layer having a thickness of 40 μm (micrometer) or more, and a tulobuterol The present invention relates to a transdermal absorption preparation contained in the matrix layer in a completely dissolved state at a concentration of 1% by weight to less than 5% by weight. |